Biography

Dr. Sherman received an M.D. from the University of Chicago in 1983, completed a pathology residency at the New England Deaconess Hospital in 1987 and a fellowship in cytopathology at Montefiore Medical Center in 1988. Prior to joining the National Cancer Institute in 2001, he was an Associate Professor of Pathology and Director of Breast Pathology at The Johns Hopkins University School of Medicine.

Research Interests

• Molecular epidemiology of gynecologic tumors and breast cancer
• Etiology of breast cancer, including investigation of non-genetic and genetic factors and mammographic density
• Risk assessment, biomarker discovery and screening
• Development of high throughput methods for analysis of tissues, especially the development of tissue microarrays
• Identification of biomarkers for screening and understanding imtermediate stages in carcinogenesis

Keywords

• Breast Cancer, Gynecologic Cancer, Hormonal Carcinogenesis, Molecular Pathology

Selected Publications

• Falk RT, Gentzschein E, Stanczyk FZ, Brinton LA, Garcia-Closas, Ioffe OB, Sherman ME. Measurement of sex steroid hormones in breast adipocytes: methods and implications. Cancer Epidemiol Biomarkers Prev 2009 17:189-5.1
• Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 2008 100:1643-8.
• Lacey Jr JV, Ioffe OB, Ronnett BM, rush BB, Glass AG, Richesson DA, Chatterjee N, Langholz B, Mutter GL, Sherman ME. PTEN expression in endometrial biopsies of women who did vs. did not progress to endometrial carcinoma. Cancer Res 2008;68:6014-20.
• Lacey Jr JV, Ioffe O, Ronnett BM, Rush BB, Richardson D, Chatterjee N, Langholz B, Glass AG, Sherman ME. Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: A 34-year experience in a large health plan. Br J Cancer 2008;98:45-53.
• Gail MH, Anderson WF, Garcia-Closas M, Sherman ME. Absolute risk models for subtypes of breast cancer. J Natl Cancer Inst 2007 99:1657-9.

Collaborators

DCEG Collaborators

• Montserrat Garcia-Closas, M.D., Ph.D, Louise Brinton, Ph.D., Jonine Figueroa, Ph.D., Gretchen Gierach, Ph.D, Nicholas Wentzensen, M.D., Ph.D., Mark Greene, M.D., William F. Anderson, M.D., Ph.D.

Other NCI Collaborators

• Diane Solomon, M.D., Barbara Vonderhaar, Ph.D., Lalage Wakefield, D. Phil, Paul Meltzer, M.D., Ph.D., Stephen Hewitt, M.D., Ph.D.

Other ScientificCollaborators

• Georgia Chenevix-Trench, Ph.D., Queensland Institute of Medical Research, Brisbane, Australia
• Neb Duric, Ph.D., Karmanos Cancer Institute, Detroit, MI
• Berta Geller, Ph.D., University of Vermont, Burlington, VT
• Andrew Glass, M.D.; David Scott, M.D., Portland Kaiser-Permanente, Portland, Oregon
• Richard Guido, M.D., Magee Women’s Hospital, Pittsburgh, PA
• Olga Ioffe, M.D., University of Maryland School of Medicine, Baltimore, Maryland
• Peter Laird, M.D., Ph.D., University of Southern California, Los Angeles, CA
• Paul Levine, M.D., George Washington University School of Public Health, Washington, D.C.
• Jolanta Lissowska, Ph.D., Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
• Alan Meeker, Ph.D., Johns Hopkins, Baltimore, MD
• Paul Pharoah, M.D., Cambridge Research Institute, Cambridge, UK
• David Rimm, M.D., Ph.D., Yale University, New Haven, CT
• Brigitte Ronnett, M.D., Johns Hopkins, Baltimore, MD;
• John Shepherd, Ph.D., University of California at San Francisco, San Francisco, CA
• Frank Stanczyk, Ph.D., University of Southern California, Los Angeles, CA
• Melissa Troester, Ph.D., University of North Carolina